Date of report (Date of earliest event reported) | June 6, 2019 |
Marsh & McLennan Companies, Inc. |
(Exact Name of Registrant as Specified in Charter) |
Delaware | 1-5998 | 36-2668272 |
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
1166 Avenue of the Americas, New York, NY | 10036 |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code | (212) 345-5000 |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Emerging growth company o | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o |
99.1 | Supplemental Financial Schedules issued by Marsh & McLennan Companies, Inc. on June 6, 2019. |
MARSH & McLENNAN COMPANIES, INC. | |||
By: | /s/ Katherine J. Brennan | ||
Name: | Katherine J. Brennan | ||
Title: | Deputy General Counsel, Chief Compliance Officer & Corporate Secretary |
First Quarter | Second Quarter | Third Quarter | Fourth Quarter | Full Year | ||||||||||||||||
Specialty | $ | 244 | $ | 352 | $ | 259 | $ | 406 | $ | 1,261 | ||||||||||
Reinsurance | 124 | 74 | 33 | 48 | 279 | |||||||||||||||
Fiduciary Interest Income | 3 | 4 | 5 | 5 | 17 | |||||||||||||||
Health & Benefits | 86 | 86 | 86 | 99 | 357 | |||||||||||||||
Total Revenue | $ | 457 | $ | 516 | $ | 383 | $ | 558 | $ | 1,914 |
First Quarter | Second Quarter | Third Quarter | Fourth Quarter | Full Year | |||||||||||||||
Revenue | $ | 457 | $ | 516 | $ | 383 | $ | 558 | $ | 1,914 | |||||||||
Expense: | |||||||||||||||||||
Compensation and Benefits | 314 | 318 | 300 | 278 | 1,210 | ||||||||||||||
Other Operating Expenses | 117 | 115 | 103 | 146 | 481 | ||||||||||||||
Operating Expenses | 431 | 433 | 403 | 424 | 1,691 | ||||||||||||||
Operating Income | $ | 26 | $ | 83 | $ | (20 | ) | $ | 134 | $ | 223 | ||||||||
Noteworthy Items: | |||||||||||||||||||
Restructuring | 12 | 12 | 6 | 7 | 37 | ||||||||||||||
Regulatory Review | — | 2 | — | 47 | 49 | ||||||||||||||
Other | — | — | — | 4 | 4 | ||||||||||||||
Total Adjustments | $ | 12 | $ | 14 | $ | 6 | $ | 58 | $ | 90 | |||||||||
Supplemental Adjusted Operating Income | $ | 38 | $ | 97 | $ | (14 | ) | $ | 192 | $ | 313 |